[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR0314036A - Apresentações farmacêuticas com mascaramento de sabor e processo para sua preparação - Google Patents

Apresentações farmacêuticas com mascaramento de sabor e processo para sua preparação

Info

Publication number
BR0314036A
BR0314036A BR0314036-9A BR0314036A BR0314036A BR 0314036 A BR0314036 A BR 0314036A BR 0314036 A BR0314036 A BR 0314036A BR 0314036 A BR0314036 A BR 0314036A
Authority
BR
Brazil
Prior art keywords
taste
masking
preparation
pharmaceutical presentations
presentations
Prior art date
Application number
BR0314036-9A
Other languages
English (en)
Inventor
Deepak Murpani
Vinod Kumar Arora
Rajiv Malik
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of BR0314036A publication Critical patent/BR0314036A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"APRESENTAçõES FARMACêUTICAS COM MASCARAMENTO DE SABOR E PROCESSO PARA SUA PREPARAçãO". A presente invenção se refere a apresentações farmacêuticas com mascaramento de sabor utilizando baixas quantidades de polímero de mascaramento de sabor e a processos simples e económicos para preparação das apresentações farmacêuticas com mascaramento de sabor. A apresentação farmacêutica com mascaramento de sabor inclui uma ou mais drogas e um ou mais polímeros catiónicos sintetizados a partir de metacrilato de dimetilaminoetila e ésteres neutros de ácido metacrílico. A relação peso/peso da droga para o polímero é menor que cerca de um para dois.
BR0314036-9A 2002-09-04 2003-09-04 Apresentações farmacêuticas com mascaramento de sabor e processo para sua preparação BR0314036A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN903DE2002 2002-09-04
PCT/IB2003/003779 WO2004022037A1 (en) 2002-09-04 2003-09-04 Taste masked dosage forms and processes for their preparation

Publications (1)

Publication Number Publication Date
BR0314036A true BR0314036A (pt) 2005-07-12

Family

ID=31972125

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314036-9A BR0314036A (pt) 2002-09-04 2003-09-04 Apresentações farmacêuticas com mascaramento de sabor e processo para sua preparação

Country Status (9)

Country Link
US (1) US20060039981A1 (pt)
EP (1) EP1536774A1 (pt)
JP (1) JP2006502156A (pt)
CN (1) CN1688292A (pt)
AU (1) AU2003259417A1 (pt)
BR (1) BR0314036A (pt)
CA (1) CA2497176A1 (pt)
RU (1) RU2005109909A (pt)
WO (1) WO2004022037A1 (pt)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US20040258752A1 (en) * 2003-01-31 2004-12-23 Paruthi Manoj Kumar Taste masking pharmaceutical composition and process for its preparation
US7470791B2 (en) 2003-03-10 2008-12-30 Nycomed Gmbh Process for the preparation of roflumilast
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
MX2007004741A (es) 2004-10-21 2007-09-07 Eurand Pharmaceuticals Ltd Composiciones farmaceuticas con sabor enmascarado con formadores de poro gastrosolubles.
WO2006070845A1 (ja) * 2004-12-28 2006-07-06 Eisai R & D Management Co., Ltd. 速崩壊性錠剤及びその製造方法
MX2007008320A (es) * 2005-01-06 2007-09-07 Cima Labs Inc Sistema enmascarador de sabor para farmacos no plastificantes.
CA2601250C (en) 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US20070009589A1 (en) * 2005-07-07 2007-01-11 Kandarapu Raghupathi Extended release compositions
WO2007087188A2 (en) * 2006-01-20 2007-08-02 Merck & Co., Inc. Taste-masked tablets and granules
WO2007134845A2 (en) * 2006-05-18 2007-11-29 Synthon B.V. Olanzapine pharmaceutical composition
US8637076B2 (en) 2006-06-01 2014-01-28 Cima Labs Inc. Prednisolone salt formulations
US20080031947A1 (en) * 2006-07-24 2008-02-07 Cima Labs Inc. Orally dissolvable/disintegrable lyophilized dosage forms containing protected
US9744137B2 (en) 2006-08-31 2017-08-29 Supernus Pharmaceuticals, Inc. Topiramate compositions and methods of enhancing its bioavailability
WO2008061226A2 (en) * 2006-11-17 2008-05-22 Supernus Pharmaceuticals Inc. Sustained-release formulations of topiramate
MX2009003911A (es) * 2006-12-04 2009-05-28 Supernus Pharmaceuticals Inc Formulaciones de liberacion inmediata, mejoradas de topiramato.
WO2009078034A2 (en) * 2007-11-26 2009-06-25 Rubicon Research Private Limited Oral disintegrating tablets of ropinirole hydrochloride
WO2009084041A2 (en) * 2008-01-01 2009-07-09 Shasun Chemicals And Drugs Limited Pharmaceutical compositions of dexibuprofen
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
FR2949061B1 (fr) 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
TWI471146B (zh) 2009-12-02 2015-02-01 Aptalis Pharma Ltd 菲索特芬那定（ｆｅｘｏｆｅｎａｄｉｎｅ）微膠囊及包含其之組合物
US20110281852A1 (en) * 2010-03-22 2011-11-17 Gareth Davies Pharmaceutical compositions containing berberine for treatment or prevention of weight gain and obesity associated with anti-psychotic drugs
US20130115300A1 (en) 2010-04-12 2013-05-09 Uma Rajan Javeri Ciprofloxacin dry syrup composition
US10004682B2 (en) 2010-08-24 2018-06-26 Rutgers, The State University Of New Jersey Formulation and manufacture of pharmaceuticals by impregnation onto porous carriers
FR2967066B1 (fr) * 2010-11-04 2013-06-14 Ethypharm Sa Utilisation par voie sublinguale de microgranules non comprimes
WO2013076216A1 (en) 2011-11-24 2013-05-30 Synthon Bv Controlled release particles comprising dimethyl fumarate
WO2013156163A1 (en) 2012-04-19 2013-10-24 Glatt Ag Taste-masked pharmaceutical compositions containing diclofenac
AU2014228861B2 (en) * 2013-03-15 2018-05-24 Aprecia Pharmaceuticals LLC Rapidly dispersible dosage form of topiramate
MX364381B (es) 2013-03-15 2019-04-25 Aprecia Pharmaceuticals LLC Forma de dosificacion de oxcarbazepina dispersable rapidamente.
GB201316857D0 (en) * 2013-09-23 2013-11-06 Buckley Howard Composition for the oral delivery of compounds
CN104644574B (zh) * 2013-11-18 2017-08-01 深圳海王医药科技研究院有限公司 一种枸橼酸西地那非掩味制剂
CN104013583B (zh) * 2014-06-27 2019-02-26 国药集团致君（深圳）制药有限公司 一种泰比培南酯组合物的药物制剂及其制备方法
CN104306338A (zh) * 2014-09-24 2015-01-28 万特制药(海南)有限公司 一种含有丙烯酸树脂及地氯雷他定的颗粒剂及其制备方法
CN105982860B (zh) * 2015-02-11 2020-04-14 北京科信必成医药科技发展有限公司 愈创甘油醚无水吞服掩味颗粒
WO2017017679A1 (en) * 2015-07-29 2017-02-02 Dexcel Pharma Technologies Ltd. Compositions comprising atorvastatin or a pharmaceutically acceptable salt thereof
CN107625741A (zh) * 2016-07-18 2018-01-26 北京科信必成医药科技发展有限公司 一种掩味包衣制剂及其制备方法
CN106580886A (zh) * 2016-12-05 2017-04-26 北京万全德众医药生物技术有限公司 一种双氯芬酸钾散剂及其制备方法
CN107412174A (zh) * 2017-03-27 2017-12-01 北京万全德众医药生物技术有限公司 一种富马酸卢帕他定口崩片及其制备方法
WO2019034712A1 (en) 2017-08-17 2019-02-21 F. Hoffmann-La Roche Ag NOVEL PHARMACEUTICAL COMPOSITIONS FOR BASIC OR NEUTRAL COMPOUNDS OF LOW MOLECULAR WEIGHT
EP3883546A1 (en) 2018-11-21 2021-09-29 Rosemont Pharmaceuticals Ltd Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
CN114522166B (zh) * 2022-04-22 2022-09-30 北京剂泰医药科技有限公司 一种固体分散体组合物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758437A (en) * 1981-12-23 1988-07-19 Yamanouchi Pharmaceutical Co., Ltd. Composition for long acting nicardipine preparation and process of producing the composition
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
US4708867A (en) * 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
US5286489A (en) * 1985-08-26 1994-02-15 The Procter & Gamble Company Taste masking compositions
US4760093A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US5275823A (en) * 1989-04-27 1994-01-04 Smith Kline & French Laboratories Ltd. Pharmaceutical compositions
US5049374A (en) * 1989-11-28 1991-09-17 Dansereau Richard J Oral (coated bead) dosage form for sodium iodide I-131
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
JP3469926B2 (ja) * 1993-11-04 2003-11-25 太田製薬株式会社 大腸内放出型医薬製剤用粒状物
WO1999017742A2 (en) * 1997-10-03 1999-04-15 Elan Corporation, Plc Taste masked formulations
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Also Published As

Publication number Publication date
AU2003259417A1 (en) 2004-03-29
EP1536774A1 (en) 2005-06-08
CN1688292A (zh) 2005-10-26
US20060039981A1 (en) 2006-02-23
JP2006502156A (ja) 2006-01-19
RU2005109909A (ru) 2006-10-10
CA2497176A1 (en) 2004-03-18
WO2004022037A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
BR0314036A (pt) Apresentações farmacêuticas com mascaramento de sabor e processo para sua preparação
Wang et al. Curcumin produces neuroprotective effects via activating brain-derived neurotrophic factor/TrkB-dependent MAPK and PI-3K cascades in rodent cortical neurons
JP6938465B2 (ja) カンナビノイドとｎ−アシルエタノールアミンの組み合わせ
ES2907325T3 (es) Tratamiento de síndrome del cromosoma X frágil y autismo con cannabidiol
ATE368066T1 (de) Hydrophiles polymerderivat mit y-verzweigung und herstellungsverfahren dafür; obige verbindung enthaltender medizinischer verbundwerkstoff
Wang et al. Effect of Praeruptorin C on 3-nitropropionic acid induced Huntington’s disease-like symptoms in mice
US20060142390A1 (en) Treatment for severe melancholic depression
Deb et al. Garcinol, a multifaceted sword for the treatment of Parkinson's disease
BR0211794A (pt) Composição farmacêutica e método para mascarar o sabor de pelo menos um composto farmaceuticamente ativo de sabor desagradável
TW200738228A (en) Neramexane modified release matrix tablet
MA30584B1 (fr) Ester de dha et son utilisation dans le traitement et la prevention des maladies cardiovasculaires
BR112013004440B1 (pt) composição farmacêutica e seu uso, kit e sistema farmacêutico para administração parenteral
Grossman et al. Cannabis and orofacial pain: a systematic review
BRPI0208468B8 (pt) camsilato de amlodipina e processo para sua preparação
RU2008103281A (ru) Способы и композиции для профилактики и лечения воспалительного заболевания
MXPA05013645A (es) Nuevos compuestos moduladores de los receptores de tipo ppar gama y su utilizacion en composiciones cosmeticas o farmaceuticas.
CA2191790A1 (fr) Composes biaromatiques portant un groupement adamantyl en para, compositions pharmaceutiques et cosmetiques les contenant et utilisations de ces compositions
CN101932316A (zh) 药物制剂及其制备和其在治疗疼痛相关的神经病中的应用
Wu et al. Acetoacetate improves memory in Alzheimer’s mice via promoting brain-derived neurotrophic factor and inhibiting inflammation
Nair et al. Biowaiver monographs for immediate release solid oral dosage forms: amodiaquine hydrochloride
CA2170065A1 (fr) Composes bi-aromatiques derives d'amide, compositions pharmaceutiques et cosmetiques les contenant et utilisations
Lin et al. Astaxanthin inhibits glutamate release in rat cerebral cortex nerve terminals via suppression of voltage-dependent Ca2+ entry and mitogen-activated protein kinase signaling pathway
BRPI0407438A (pt) Sistema terapêutico compreendendo amoxicilina e ácido clavulânico
JPH09500121A (ja) 痴呆症の治療のためのナブメトンまたは６−メトキシナフチル酢酸の使用
BRPI0415322A (pt) composição farmacêutica antiretroviral, processo para a preparação de uma composição farmacêutica antiretroviral, método para reduzir a carga de consumo de pìlulas para um paciente, método para aumentar a meia-vida in vivo de lamivudina e de zidovudina enquanto não afetando a meia-vida de nevirapina

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]